Largest FDA-authorized Phase 2 cell therapy trial conducted in chronic lumbar disc diseaseThe study has enrolled a total of ...
Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...
The Rapid RCT Lab is a nationally-leading team conducting innovative, rapid RCTs to improve the delivery of services at the ...
A novel collaboration may establish a framework to help researchers overcome regulatory barriers they often face when ...
How an excessive focus on methods has distracted attention from the more fundamental challenge of building rigor and learning ...
Leading vaccine researchers say that the proposed vaccine trials could lead to unreliable conclusions on already-approved ...
The benefits of exercise are limited, disappear if discontinued, and should be an adjunct to talk or drug therapy.
In this live interview on Bloomberg World, Dr. Raza Bokhari, Executive Chairman and CEO of Medicus Pharma, discusses the ...
In combined analysis (n = 39), the average wound closure rate was 98%, and all 19 patients previously diagnosed for potential ...
The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is part of a larger communications crisis unfolding at the agency over the past nine months that has also ensnarled Sarepta, Capricor, ...
Morning Overview on MSN
1-year study finds Nektar eczema drug keeps skin clear and under control
For people living with atopic dermatitis, the real test of any new therapy is not what it can do in a few months, but whether it can keep angry, inflamed skin quiet over the long haul. Nektar ...
Our findings indicate that a large commercial insurer is increasingly covering acupuncture for its beneficiaries. Unlike Medicare Part B, which limits acupuncture coverage to chronic low back pain, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results